IL154415A0 - Polynucleotides that encode her-2/neu polypeptides and pharmaceutical compositions containing the same - Google Patents
Polynucleotides that encode her-2/neu polypeptides and pharmaceutical compositions containing the sameInfo
- Publication number
- IL154415A0 IL154415A0 IL15441501A IL15441501A IL154415A0 IL 154415 A0 IL154415 A0 IL 154415A0 IL 15441501 A IL15441501 A IL 15441501A IL 15441501 A IL15441501 A IL 15441501A IL 154415 A0 IL154415 A0 IL 154415A0
- Authority
- IL
- Israel
- Prior art keywords
- polynucleotides
- encode
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
- A61K39/464403—Receptors for growth factors
- A61K39/464406—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22515200P | 2000-08-14 | 2000-08-14 | |
US23642800P | 2000-09-28 | 2000-09-28 | |
US27052001P | 2001-02-21 | 2001-02-21 | |
PCT/US2001/041733 WO2002014503A2 (en) | 2000-08-14 | 2001-08-14 | Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
Publications (1)
Publication Number | Publication Date |
---|---|
IL154415A0 true IL154415A0 (en) | 2003-09-17 |
Family
ID=27397445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15441501A IL154415A0 (en) | 2000-08-14 | 2001-08-14 | Polynucleotides that encode her-2/neu polypeptides and pharmaceutical compositions containing the same |
Country Status (14)
Country | Link |
---|---|
US (1) | US20020193329A1 (xx) |
EP (1) | EP1366153A2 (xx) |
JP (1) | JP2004522412A (xx) |
KR (1) | KR20030048009A (xx) |
CN (1) | CN1537164A (xx) |
AU (1) | AU2001295008A1 (xx) |
BR (1) | BR0113235A (xx) |
CA (1) | CA2419533A1 (xx) |
HU (1) | HUP0600780A2 (xx) |
IL (1) | IL154415A0 (xx) |
MX (1) | MXPA03001389A (xx) |
NO (1) | NO20030714L (xx) |
PL (1) | PL365789A1 (xx) |
WO (1) | WO2002014503A2 (xx) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6620300A (en) | 1999-08-03 | 2001-02-19 | Ohio State University, The | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
TWI259206B (en) * | 2002-09-24 | 2006-08-01 | Univ Nat Cheng Kung | A DNA vaccine containing a tumor associated gene and a cytokine gene and the method producing thereof |
US7282365B2 (en) | 2003-01-03 | 2007-10-16 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Rhesus HER2/neu, nucleotides encoding same, and uses thereof |
JP4772674B2 (ja) * | 2003-07-21 | 2011-09-14 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | ヒト上皮成長因子2/neu抗原をコードする合成遺伝子およびその用途 |
KR101192496B1 (ko) | 2003-11-06 | 2012-10-18 | 시애틀 지네틱스, 인크. | 리간드에 접합될 수 있는 모노메틸발린 화합물 |
CN114053429A (zh) | 2004-06-01 | 2022-02-18 | 健泰科生物技术公司 | 抗体-药物偶联物和方法 |
US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
RU2412947C2 (ru) | 2004-09-23 | 2011-02-27 | Дженентек, Инк. | Антитела, сконструированные на основе цистеинов, и их конъюгаты |
CN100381460C (zh) * | 2004-11-30 | 2008-04-16 | 北京市肿瘤防治研究所 | Her-2模拟抗原表位及含有该表位的肽 |
AU2006261342B2 (en) * | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
KR101010063B1 (ko) * | 2008-07-25 | 2011-01-21 | 삼표이앤씨 주식회사 | 레일고정구조 |
US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
JP2013504585A (ja) | 2009-09-09 | 2013-02-07 | セントローズ, エルエルシー | 細胞外標的化薬物複合体 |
PE20130342A1 (es) | 2010-04-15 | 2013-04-20 | Spirogen Sarl | Pirrolobenzodiacepinas y conjugados de las mismas |
WO2011156328A1 (en) | 2010-06-08 | 2011-12-15 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
CA2816426A1 (en) | 2010-11-17 | 2012-06-07 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
CA2833212C (en) | 2011-05-12 | 2020-06-09 | Genentech, Inc. | Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides |
KR101877598B1 (ko) | 2011-10-14 | 2018-07-11 | 메디뮨 리미티드 | 피롤로벤조디아제핀 및 그의 컨주게이트 |
CN102357246B (zh) * | 2011-11-02 | 2013-04-03 | 江苏省中医药研究院 | 一种egfr与her2联合多肽表位疫苗 |
WO2013130093A1 (en) | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Biomarkers for treatment with anti-tubulin chemotherapeutic compounds |
RS56520B1 (sr) | 2012-10-12 | 2018-02-28 | Adc Therapeutics Sa | Pirolobenzodiazepin-anti-cd22 konjugati antitela |
JP6392763B2 (ja) | 2012-10-12 | 2018-09-19 | エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa | ピロロベンゾジアゼピン−抗体結合体 |
EP2906297B1 (en) | 2012-10-12 | 2017-12-06 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
ES2670937T3 (es) | 2012-10-12 | 2018-06-04 | Medimmune Limited | Conjugados de anticuerpo-pirrolobenzodiazepina |
CA2941485C (en) | 2012-10-12 | 2018-06-12 | Philip Wilson Howard | Pyrrolobenzodiazepines and conjugates thereof |
US10751346B2 (en) | 2012-10-12 | 2020-08-25 | Medimmune Limited | Pyrrolobenzodiazepine—anti-PSMA antibody conjugates |
EP2935268B2 (en) | 2012-12-21 | 2021-02-17 | MedImmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
AU2013366490B9 (en) | 2012-12-21 | 2018-02-01 | Medimmune Limited | Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases |
JP6340019B2 (ja) | 2013-03-13 | 2018-06-06 | メドイミューン・リミテッドMedImmune Limited | ピロロベンゾジアゼピン及びそのコンジュゲート |
BR112015023070B1 (pt) | 2013-03-13 | 2022-06-07 | Genentech, Inc. | Conjugados e compostos de pirrolobenzodiazepinas, composição farmacêutica que compreende os mesmo, bem como seus usos para o tratamento de uma doença proliferativa |
BR112015023333A8 (pt) | 2013-03-13 | 2018-04-17 | Medimmune Ltd | pirrolbenzodiazepinas e conjugados dos mesmos |
WO2015023355A1 (en) | 2013-08-12 | 2015-02-19 | Genentech, Inc. | 1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment |
GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
EP3054986B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
JP6980384B2 (ja) | 2013-12-16 | 2021-12-15 | ジェネンテック, インコーポレイテッド | 1−(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法 |
AU2014364927A1 (en) | 2013-12-16 | 2016-07-07 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
RU2689388C1 (ru) | 2013-12-16 | 2019-05-28 | Дженентек, Инк. | Пептидомиметические соединения и их конъюгаты антител с лекарственными средствами |
US10188746B2 (en) | 2014-09-10 | 2019-01-29 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
EP3191134B1 (en) | 2014-09-12 | 2019-11-20 | Genentech, Inc. | Anthracycline disulfide intermediates, antibody-drug conjugates and methods |
GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
RU2017107502A (ru) | 2014-09-12 | 2018-10-12 | Дженентек, Инк. | Антитела и конъюгаты, сконструированные введением цистеина |
KR20170067771A (ko) | 2014-09-17 | 2017-06-16 | 제넨테크, 인크. | 피롤로벤조디아제핀 및 이의 항체 디설파이드 컨주게이트 |
EP3223854A1 (en) | 2014-11-25 | 2017-10-04 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
KR20170086121A (ko) | 2014-12-03 | 2017-07-25 | 제넨테크, 인크. | 4급 아민 화합물 및 그의 항체-약물 접합체 |
GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
MA43345A (fr) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation |
MA43354A (fr) | 2015-10-16 | 2018-08-22 | Genentech Inc | Conjugués médicamenteux à pont disulfure encombré |
MA45326A (fr) | 2015-10-20 | 2018-08-29 | Genentech Inc | Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation |
GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
CN108700598A (zh) | 2016-03-25 | 2018-10-23 | 豪夫迈·罗氏有限公司 | 多路总抗体和抗体缀合的药物量化测定法 |
GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
WO2017201449A1 (en) | 2016-05-20 | 2017-11-23 | Genentech, Inc. | Protac antibody conjugates and methods of use |
WO2017205741A1 (en) | 2016-05-27 | 2017-11-30 | Genentech, Inc. | Bioanalytical method for the characterization of site-specific antibody-drug conjugates |
EP3464280B1 (en) | 2016-06-06 | 2021-10-06 | F. Hoffmann-La Roche AG | Silvestrol antibody-drug conjugates and methods of use |
EP3496763A1 (en) | 2016-08-11 | 2019-06-19 | Genentech, Inc. | Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof |
CN110139674B (zh) | 2016-10-05 | 2023-05-16 | 豪夫迈·罗氏有限公司 | 制备抗体药物缀合物的方法 |
GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
MX2019009428A (es) | 2017-02-08 | 2019-10-07 | Adc Therapeutics Sa | Conjugados de pirrolobenzodiazepinas y anticuerpos. |
HUE059828T2 (hu) | 2017-04-18 | 2023-01-28 | Medimmune Ltd | Pirrolobenzodiazepin konjugátumok |
JP7408396B2 (ja) | 2017-04-20 | 2024-01-05 | アーデーセー セラピューティクス ソシエテ アノニム | 併用療法 |
BR112019026564A2 (pt) | 2017-06-14 | 2020-06-30 | Adc Therapeutics Sa | regimes de dosagem para a administração de um adc anti-cd19 |
LT3668874T (lt) | 2017-08-18 | 2022-03-25 | Medimmune Limited | Pirolobenzodiazepino konjugatai |
IL302943A (en) | 2017-09-20 | 2023-07-01 | Ph Pharma Co Ltd | Thylanstatin analogs |
GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
GB201814281D0 (en) | 2018-09-03 | 2018-10-17 | Femtogenix Ltd | Cytotoxic agents |
US20210324035A1 (en) * | 2018-09-05 | 2021-10-21 | The Regents Of The University Of California | Composition of ny-eso-1-specific t cell receptors restricted on multiple major histocompatibility complex molecules |
EP3870235A1 (en) | 2018-10-24 | 2021-09-01 | F. Hoffmann-La Roche AG | Conjugated chemical inducers of degradation and methods of use |
EP3894427A1 (en) | 2018-12-10 | 2021-10-20 | Genentech, Inc. | Photocrosslinking peptides for site specific conjugation to fc-containing proteins |
GB201901197D0 (en) | 2019-01-29 | 2019-03-20 | Femtogenix Ltd | G-A Crosslinking cytotoxic agents |
GB2597532A (en) | 2020-07-28 | 2022-02-02 | Femtogenix Ltd | Cytotoxic compounds |
WO2022235045A1 (ko) | 2021-05-04 | 2022-11-10 | 주식회사 애스톤사이언스 | Her2 백신 조성물 |
KR20230017640A (ko) * | 2021-07-28 | 2023-02-06 | 주식회사 애스톤사이언스 | Her2 백신 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993014781A1 (en) * | 1992-01-24 | 1993-08-05 | The Regents Of The University Of California | Novel peptides and method for altering the activity of allosteric proteins |
US5869445A (en) * | 1993-03-17 | 1999-02-09 | University Of Washington | Methods for eliciting or enhancing reactivity to HER-2/neu protein |
US5801005A (en) * | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
WO1999045954A1 (en) * | 1998-03-13 | 1999-09-16 | Epimmune, Inc. | Hla-binding peptides and their uses |
WO1999057981A1 (en) * | 1998-05-08 | 1999-11-18 | Sloan-Kettering Institute For Cancer Research | Compositions and methods for active vaccination |
DE60044665D1 (de) * | 1999-01-29 | 2010-08-26 | Corixa Corp | Her2/neu fusionsproteine |
-
2001
- 2001-08-14 EP EP01975714A patent/EP1366153A2/en not_active Withdrawn
- 2001-08-14 MX MXPA03001389A patent/MXPA03001389A/es unknown
- 2001-08-14 HU HU0600780A patent/HUP0600780A2/hu unknown
- 2001-08-14 IL IL15441501A patent/IL154415A0/xx unknown
- 2001-08-14 WO PCT/US2001/041733 patent/WO2002014503A2/en not_active Application Discontinuation
- 2001-08-14 CN CNA018164471A patent/CN1537164A/zh active Pending
- 2001-08-14 BR BR0113235-0A patent/BR0113235A/pt not_active Application Discontinuation
- 2001-08-14 CA CA002419533A patent/CA2419533A1/en not_active Abandoned
- 2001-08-14 PL PL01365789A patent/PL365789A1/xx not_active Application Discontinuation
- 2001-08-14 AU AU2001295008A patent/AU2001295008A1/en not_active Abandoned
- 2001-08-14 JP JP2002519631A patent/JP2004522412A/ja active Pending
- 2001-08-14 KR KR10-2003-7002207A patent/KR20030048009A/ko not_active Application Discontinuation
- 2001-08-14 US US09/930,125 patent/US20020193329A1/en not_active Abandoned
-
2003
- 2003-02-14 NO NO20030714A patent/NO20030714L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CN1537164A (zh) | 2004-10-13 |
NO20030714D0 (no) | 2003-02-14 |
CA2419533A1 (en) | 2002-02-21 |
EP1366153A2 (en) | 2003-12-03 |
KR20030048009A (ko) | 2003-06-18 |
US20020193329A1 (en) | 2002-12-19 |
PL365789A1 (en) | 2005-01-10 |
WO2002014503A2 (en) | 2002-02-21 |
AU2001295008A1 (en) | 2002-02-25 |
NO20030714L (no) | 2003-04-11 |
HUP0600780A2 (en) | 2007-01-29 |
BR0113235A (pt) | 2004-06-08 |
WO2002014503A3 (en) | 2003-09-18 |
MXPA03001389A (es) | 2004-05-04 |
JP2004522412A (ja) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154415A0 (en) | Polynucleotides that encode her-2/neu polypeptides and pharmaceutical compositions containing the same | |
IL150732A0 (en) | Prostate specific polypeptides, polynucleotides that encode said polypeptides and pharmaceutical compositions containing the same | |
HUP0102372A3 (en) | Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same | |
HUP0200312A3 (en) | Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use | |
HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
HUP0100867A3 (en) | Pharmaceutical compositions containing celecoxib | |
HUP9901606A2 (en) | Pharmaceutical compositions comprising sildenaphil | |
HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
HUP0402003A3 (en) | Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof | |
HUP0103507A3 (en) | Pharmaceutical compositions comprising 2-quinolones | |
IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
GB9727053D0 (en) | Pharmaceutical compositions | |
PT1466615E (pt) | Composição farmacêutica | |
CY2569B1 (en) | Pharmaceutical compositions | |
HU9800876D0 (en) | Liquid antacid compositions | |
PL343769A1 (en) | Pharmaceutical composition | |
HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
GB9818591D0 (en) | Pharmaceutical composition | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
IL131995A0 (en) | Gastric-retained pharmaceutical compositions | |
GB9723985D0 (en) | Pharmaceutical compositions | |
GB9726735D0 (en) | Pharmaceutical compositions | |
EP1124557A4 (en) | PHARMACEUTICAL COMPOSITION | |
HU9700632D0 (en) | Pharmaceutical compositions |